Abstract

Oral Mucositis: Etiology and Clinical and Pharmaceutical Management

Author(s): Zur Eyal

Issue: Jan/Feb 2012 - Volume 16, Number 1

Page(s): 22-33

Download in electronic PDF format for $75

Abstract

Oral mucosal damage is one of the common and worst side effects of radiotherapy and chemotherapy treatment for cancer. With prevalence between 10% and 100%, depending on the cytotoxic and/or radiotherapy regimen and patient-associated variables, this morbid condition represents a significant problem in oncology. This article addresses oral mucositis and discusses its prevalence, risk factors, clinical and economical impacts, etiology, and clinical management in view of the most recent evidence. Despite clear progress and the development of clinical guidelines on this topic, what we currently have to offer to patients to manage mucositis and oropharyngeal pain is still inadequate. This article offers two compounded preparations supported by evidence-based data to treat oral mucositis. Expansion of the knowledge of the pathogenesis of mucositis as well as a better insight into individual risk factors will provide opportunities to improve management strategies.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2012 Pg. 22-33	Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Author(s): Zur Eyal
May/Jun 2009 Pg. 214-217	Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers Author(s): Young Jennifer L, Bogner Robin H
Mar/Apr 2004 Pg. 126-129	Basics of Compounding for the Treatment of Warts Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 436-440	Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Author(s): Bassani August S, Keim David
Sep/Oct 2009 Pg. 372-381	A Review of Stomatitis and Treatment in Cats Author(s): Ray Jody D, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
Mar/Apr 2012 Pg. 117-124	Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Author(s): Zur Eyal
Jan/Feb 2018 Pg. 60-65	Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing Author(s): Song Guiyun, Banov Daniel, Bassani August S
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 257-260	Surviving Cancer - How the Compounding Pharmacist Can Help Author(s): Maddox Suzan
Jul/Aug 2000 Pg. 302	Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 196-205	Burning Mouth Syndrome: A Discussion of a Complex Pathology Author(s): Zur Eyal
May/Jun 2024 Pg. 249-259	Innovative Fusion of Probiotics and Mouth Fresheners: Investigating Unaltered Growth, Microscopic Analysis, and Mucoadhesive Strength Author(s): Patel Swayamprakash, Patel Meet, Kaushik Gaurav, Patel Mruduka S, Desai Jagruti, Patel Mehul
Jul/Aug 2018 Pg. 284-287	The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Author(s): Williams LaVonn
Jan/Feb 2019 Pg. 14-21	The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Author(s): Williams LaVonn A
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2010 Pg. 68	Ketoprofen 100-mg/5-mL Mouth Rinse Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 195-198	Compounding Antiangiogenic Cancer Therapy for Animals Author(s): Davidson Gigi S
Jan/Feb 2007 Pg. 56-58	Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Author(s): Anderson Derick
Sep/Oct 2018 Pg. 412-416	Stability of Tranexamic Acid Mouth Rinse Author(s): Donnelly Ronald F
Sep/Oct 2022 Pg. 364-368	A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Author(s): Riepl Mike